Tag
2 articles published
Longevity advocate Bryan Johnson explores whether the high-stress cryptocurrency industry accelerates biological aging through a proposed biomarker study.
NewLimit secures $435M in Series C funding led by Founders Fund to transition its cellular reprogramming research into human clinical trials for age reversal.
Get breaking news, market analysis, and expert insights delivered to your inbox daily.
Free. No spam. Unsubscribe anytime.